NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Vesselon, Inc.

Vesselon, Inc.

Private
Norwalk, ConnecticutHealthcare & Life Scienceshttps://vesselon.com/

Last Round

Accelerator

Feb 2, 2018

Total Funding Raised

$150,000

Company Overview

Vesselon, Inc. is a biotechnology company that develops patentable drug co-formulations using an FDA-approved, biophysically activated lipid microsphere and self-assembling liposomes to enhance the cellular uptake and efficacy of intravenous therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Medical Imaging, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

drug deliverylipid microsphereultrasound-mediated deliverysonoporationdrug co-formulationlife cycle managementpatent life extensiontargeted therapybiotech licensingintravenous therapydrug delivery platformdrug repurposingtherapeutic indexprecision medicinedrug delivery tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vesselon, Inc. Comparables

Compare Vesselon, Inc. with similar companies based on industry and business-model similarity.

Vesselon, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Artenga Inc.
86%
Advanced Microbubbles, Inc.
81%
OxSonics Therapeutics
77%

Vesselon, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorFeb 2, 2018
Convertible DebtOct 26, 2016
Convertible DebtJun 6, 2016

Key People

Founding team and executive leadership

Clay Larsen

President and CEO, Co-Founder

Founding Team

Vesselon, Inc. Investors

Notable investors and investment history

Vesselon, Inc. investors
InvestorRounds
Accelerator for Biosciences in ConnecticutAccelerator

Vesselon, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Vesselon, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Vesselon, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersNorwalk, Connecticut
Employee Range2
Year Founded2012
Last FundingFeb 2, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.